The offering provides Tharimmune with additional growth capital to support the continued expansion and development of its Canton-centric digital asset treasury strategy, as well as additional general working capital. In addition to its activities on the Canton Network, Tharimmune also operates clinical-stage biotech research and development.
The Reed Smith deal team was led by Yuta Delarck and Baihan Li and included Marcela Barba, Michael S. Lee, Yun Ling, Diamond Boardley, and Giulia Piccininni.
Reed Smith previously advised DRW, a diversified trading firm, as a lead investor in Tharimmune’s $545 million private placement supporting the establishment of a Canton Coin treasury strategy.
About Reed Smith
Reed Smith is a dynamic international law firm dedicated to helping clients move their businesses forward. With an inclusive culture and innovative mindset, we deliver smarter, more creative legal services that drive better outcomes for our clients. Our deep industry knowledge, long-standing relationships and collaborative structure make us the go-to partner for complex disputes, transactions, and regulatory matters.
